Moderna mRNA Portfolio on Track to Hit 2025 Goal with Nipah Virus Trial Launch 0 12.07.2022 03:00 Feedity.com Moderna has dosed its first participant in a Phase I clinical trial of mRNA-1215, a vaccine designed to fight the Nipah virus (NiV), a virus contracted in humans through animals. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
